FDA NDC Directory · JSON-LD · Markdown

Rybrevant Faspro

NDC 57894-515 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameAMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761484
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsAMIVANTAMAB (2400 mg/15mL)
HYALURONIDASE (HUMAN RECOMBINANT) (30000 mg/15mL)
Marketing started20260213
Package count1

External sources

Source: openFDA. Public-domain (CC0).